Publication Type:

Journal Article


Research Journal of Pharmacy and Technology, Raipur, Volume 12, Issue 3 (2019)



chronic pancreatitis, Malabsorption., pancreatic enzymes, Pseudocyst, type3c DM


<p>Aim: There are no guidelines for use of diabetic medications in pancreatic diabetes. Hence we attempted to the<br />benefits of antidiabetic agents in pancreatic diabetes. Materials and methods: a total of 670 chronic pancreatitis<br />patients are selected. Out of that about 126 patients with pancreatic diabetic are selected for the study. The data<br />collected from 2010. Results: In this study mean age was found to be 53.86&plusmn;12.53. The male patients (73.8%)<br />were more predominant in this study than female patients (26.2%). The complications of chronic pancreatitis<br />among 126 patients, 126 (100) patient had diabetes mellitus (DM), 100 (79) patients had pain. Among 126<br />patients 52 (41.3%) patients had taken insulin only, 21 (16.7%) patients had taken insulin+ oral combination, 16<br />(12.7%) patients had taken Biguanides, 13 (10.3%) of patients had taken oral combinations, 13 (10.3%) patients<br />had taken alpha glucosidase inhibitors, 11 (8.7%) patients who are taken sulfonyl ureas. Most of the patients<br />took insulin monotherapy. Conclusion: Insulin was most preferred agent. Metformin was the most commonly<br />preferred oral antidiabetic agent.</p>

Cite this Research Publication

K. D. Salima, Dr Rajesh Gopalakrishna, Renjitha Bhaskaran, and R., R. P., “Physician Preference of Anti-diabetic Medications and Complications in Pancreatic Diabetes - An Experience from A Tertiary Care Teaching Hospital”, Research Journal of Pharmacy and Technology, Raipur, vol. 12, no. 3, 2019.